The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
Open accessAbstract
We studied the immunocytochemical localization of urokinase-type plasminogen activator (u-PA) and the type 1 plasminogen activator inhibitor (PAI-1) in human fibroblasts and sarcoma cells, using both polyclonal and monoclonal antibodies. The u-PA was found to be located at discrete cell-substratum contact sites, and also at areas of cell-cell contacts, whereas PAI-1 was distributed as a homogeneous carpet excluding strialike areas on the substrate under the cells. To confirm the extracellular localization of u-PA and PAI-1, we stained the cells live at 0 degree C before fixation. A double-labeling experiment showed different distribution of u-PA and PAI-1 under the cells, and especially their peripheral parts. The staining pattern of u-PA and PAI-1 resisted treatment with 0.2% saponin followed by mechanical removal of cells, a method previously reported to isolate focal contact membranes of fibroblasts. We further demonstrated the deposition of u-PA to the contact areas of cells obtained by saponin treatment by zymography, and that of PAI-1 by metabolic labeling, reverse zymography, immunoblotting, and immunoprecipitation. Fibronectin was also present in the preparations. The deposition of both PAI-1 and fibronectin by the sarcoma cells was enhanced, after treating the cells with 10(-6) M dexamethasone. The confinement of u-PA to discrete contact sites and the more uniform distribution of PAI-1 on the cell substratum may explain how cells producing large amounts of enzyme inhibitors can produce PA-mediated focal proteolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
A better cell line for making hybridomas secreting specific antibodies
SHULMAN, M., WILDE, C. D., & KÖHLER, G. (1978) · Nature · doi:10.1038/276269a0 · Cited by 1,605
On the Regulation and Control of Fibrinolysis: Edward Kowalski Memorial Lecture
Collen, D. (1980) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650023 · Cited by 1,135
A study of proteases and protease-inhibitor complexes in biological fluids
Granelli-Piperno, A., & Reich, E. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.223 · Cited by 803
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Synthesis of fibrinolytic activator and inhibitor by endothelial cells
Loskutoff, D. J., & Edgington, T. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3903 · Cited by 479
van Mourik, J. A., Lawrence, D. A., & Loskutoff, D. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42691-3 · Cited by 450
Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
Hayman, E. G., Pierschbacher, M. D., Ohgren, Y., & Ruoslahti, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.4003 · Cited by 450
Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F., & Assoian, R. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4939 · Cited by 443
Plasminogen activation and regulation of pericellular proteolysis
Saksela, O. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90014-9 · Cited by 436
Self-citationVassalli, J. D., Dayer, J. M., Wohlwend, A., & Belin, D. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.6.1653 · Cited by 401
Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
Erickson, L. A., Ginsberg, M. H., & Loskutoff, D. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111559 · Cited by 356
Verheijen, J. H., Chang, G. T. G., & Kluft, C. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661109 · Cited by 338
Protease nexin. Properties and a modified purification procedure.
Scott, R. W., Bergman, B. L., Bajpai, A., Hersh, R. T., Rodriguez, H., Jones, B. N., Barreda, C., Watts, S., & Baker, J. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88883-4 · Cited by 275
Nielsen, L. S., Hansen, J. G., Skriver, L., Wilson, E. L., Kaltoft, K., Zeuthen, J., & Danoe, K. (1982) · Biochemistry · doi:10.1021/bi00268a014 · Cited by 257
Self-citationVartio, T., Seppä, H., & Vaheri, A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70161-6 · Cited by 252
Self-citationLevin, E. G. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.22.6804 · Cited by 251
Andreasen, P. A., Nielsen, L. S., Kristensen, P., Grøndahl-Hansen, J., Skriver, L., & Danø, K. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57447-6 · Cited by 228
Self-citationChapman Jr., H. A., Vavrin, Z., & Hibbs Jr., J. B. (1982) · Cell · doi:10.1016/0092-8674(82)90220-3 · Cited by 219
External fibronectin of cultured human fibroblasts is predominantly a matrix protein.
Hedman, K., Vaheri, A., & Wartiovaara, J. (1978) · The Journal of cell biology · doi:10.1083/jcb.76.3.748 · Cited by 216
Self-citationSalo, T., Liotta, L. A., Keski‐Oja, J., Turpeenniemi‐Hujanen, T., & Tryggvason, K. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300520 · Cited by 195
Wiman, B., Chmielewska, J., & Rånby, M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43143-7 · Cited by 187
Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites.
Chen, W. T., Olden, K., Bernard, B. A., & Chu, F. F. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.4.1546 · Cited by 185
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
Salonen, E. M., Saksela, O., Vartio, T., Vaheri, A., Nielsen, L. S., & Zeuthen, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39025-7 · Cited by 174
Self-citationImmunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.
Skriver, L., Larsson, L. I., Kielberg, V, Nielsen, L. S., Andresen, P. B., Kristensen, P., & Danø, K. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.2.753 · Cited by 169
Self-citationACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS
Reich, E. (1978) · Molecular Basis of Biological Degradative Processes · doi:10.1016/b978-0-12-092150-8.50011-4 · Cited by 169
Human endothelial cells contain one type of plasminogen activator
Kristensen, P. L., Larsson, L., Nielsen, L. S., Grøndahl-Hansen, J., Andreasen, P. A., & Danø, K. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80201-x · Cited by 156
Self-citationO’Grady, R. L., Upfold, L. I., & Stephens, R. W. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280418 · Cited by 146
Oliver, N., Newby, R. F., Furcht, L. T., & Bourgeois, S. (1983) · Cell · doi:10.1016/0092-8674(83)90357-4 · Cited by 134
Characterization of human serum spreading factor with monoclonal antibody.
Barnes, D. W., Silnutzer, J., See, C., & Shaffer, M. C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1362 · Cited by 124
CARTER, W. G., & Hakomori, S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69083-6 · Cited by 124
Laminin interacts with plasminogen and its tissue‐type activator
Salonen, E., Zitting, A., & Vaheri, A. I. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80866-2 · Cited by 112
Self-citationAvnur, Z., & Geiger, B. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90283-7 · Cited by 109
Holmberg, L., Lecander, I., Persson, B., & Åstedt, B. (1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90216-7 · Cited by 107
Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes
Ichinose, A., Kisiel, W., & Fujikawa, K. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80779-6 · Cited by 83
Keski‐Oja, J., & Vaheri, A. I. (1982) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(82)90005-2 · Cited by 73
Self-citationBasal lamina glycoproteins are produced by neuroblastoma cells
Alitalo, K. K., Kurkinen, M. T., Vaheri, A. I., Virtanen, I., Rohde, H., & Timpl, R. (1980) · Nature · doi:10.1038/287465a0 · Cited by 68
Self-citation
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Self-citationCell-Associated Plasminogen Activation: Regulation and Physiological Functions
Saksela, O., & Rifkin, D. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.000521 · Cited by 818
Self-citationGelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
Self-citationTumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Metadata
- Authors
- Pöllänen, J., Saksela, O., Salonen, E., Andreasen, P., Nielsen, L., Danø, K., & Vaheri, A.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1987-04-01
- Volume
- 104
- Issue
- 4
- Pages
- 1085-1096
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2089693544
- Cited by
- 292
- References
- 40
- FWCI
- 24.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.